Kezar Life Sciences Inc. (KZR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Kezar Life Sciences Statistics
Share Statistics
Kezar Life Sciences has 7.30M shares outstanding. The number of shares has increased by -89.98% in one year.
Shares Outstanding | 7.30M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -90% |
Owned by Institutions (%) | n/a |
Shares Floating | 6.22M |
Failed to Deliver (FTD) Shares | 1 |
FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 177.96K, so 2.44% of the outstanding shares have been sold short.
Short Interest | 177.96K |
Short % of Shares Out | 2.44% |
Short % of Float | 2.87% |
Short Ratio (days to cover) | 0.93 |
Valuation Ratios
The PE ratio is -6.74 and the forward PE ratio is -0.72.
PE Ratio | -6.74 |
Forward PE | -0.72 |
PS Ratio | 98.15 |
Forward PS | 6.7 |
PB Ratio | 3.66 |
P/FCF Ratio | -8.23 |
PEG Ratio | n/a |
Enterprise Valuation
Kezar Life Sciences Inc. has an Enterprise Value (EV) of 87.67M.
EV / Earnings | -0.86 |
EV / Sales | 12.52 |
EV / EBITDA | -0.88 |
EV / EBIT | -0.83 |
EV / FCF | -1.05 |
Financial Position
The company has a current ratio of 11.66, with a Debt / Equity ratio of 0.1.
Current Ratio | 11.66 |
Quick Ratio | 11.66 |
Debt / Equity | 0.1 |
Total Debt / Capitalization | 9.17 |
Cash Flow / Debt | -4.31 |
Interest Coverage | -67.89 |
Financial Efficiency
Return on equity (ROE) is -0.54% and return on capital (ROIC) is -50.96%.
Return on Equity (ROE) | -0.54% |
Return on Assets (ROA) | -0.46% |
Return on Capital (ROIC) | -50.96% |
Revenue Per Employee | 120.69K |
Profits Per Employee | -1.76M |
Employee Count | 58 |
Asset Turnover | 0.03 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -20.37% in the last 52 weeks. The beta is 0.22, so Kezar Life Sciences 's price volatility has been higher than the market average.
Beta | 0.22 |
52-Week Price Change | -20.37% |
50-Day Moving Average | 6.91 |
200-Day Moving Average | 14.64 |
Relative Strength Index (RSI) | 33.96 |
Average Volume (20 Days) | 58.12K |
Income Statement
In the last 12 months, Kezar Life Sciences had revenue of 7.00M and earned -101.87M in profits. Earnings per share was -1.4.
Revenue | 7.00M |
Gross Profit | 5.93M |
Operating Income | -105.24M |
Net Income | -101.87M |
EBITDA | -99.25M |
EBIT | -105.24M |
Earnings Per Share (EPS) | -1.4 |
Balance Sheet
The company has 35.49M in cash and 18.93M in debt, giving a net cash position of 16.56M.
Cash & Cash Equivalents | 35.49M |
Total Debt | 18.93M |
Net Cash | 16.56M |
Retained Earnings | -350.76M |
Total Assets | 164.09M |
Working Capital | 135.95M |
Cash Flow
In the last 12 months, operating cash flow was -81.64M and capital expenditures -1.81M, giving a free cash flow of -83.45M.
Operating Cash Flow | -81.64M |
Capital Expenditures | -1.81M |
Free Cash Flow | -83.45M |
FCF Per Share | -1.15 |
Margins
Gross margin is 84.77%, with operating and profit margins of -1.50K% and -1.46K%.
Gross Margin | 84.77% |
Operating Margin | -1.50K% |
Pretax Margin | -1.46K% |
Profit Margin | -1.46K% |
EBITDA Margin | -1.42K% |
EBIT Margin | -1.50K% |
FCF Margin | -1.19K% |
Dividends & Yields
KZR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -21.84% |
FCF Yield | -178.35% |
Analyst Forecast
The average price target for KZR is $9, which is 40.4% higher than the current price. The consensus rating is "Hold".
Price Target | $9 |
Price Target Difference | 40.4% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Stock Splits
The last stock split was on Oct 30, 2024. It was a backward split with a ratio of 1:10.
Last Split Date | Oct 30, 2024 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | -3.61 |
Piotroski F-Score | 2 |